A landmark clinical study in the Lancet provides convincing evidence that a frequently overlooked therapy for genetically-caused emphysema is effective and slows the progression of lung disease. Alpha ...

Visually assessed pulmonary emphysema independently predicted modestly elevated all-cause mortality risk over 25 years of follow-up in patients with a history of smoking. After controlling for other ...

Please provide your email address to receive an email when new articles are posted on . Adults with a low-dose CT scan between June 2000 and December 2008 were followed for a median of 23.3 years.